Find Resources
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
White Paper/Brief
This article discusses the Foundation for Opioid Response Efforts (FORE) distribution of $1.3 million in grants to organizations studying the potential permanent adoption of COVID-19 care access measures to promote health equity in opioid use disorder treatment. The grants aim to investigate the impact of temporary policies, such as virtual care, on access to care and patient outcomes. The studies will explore how relaxed prescribing policies for buprenorphine, telehealth strategies, and other COVID-19 measures have affected patient access and outcomes, particularly among underserved populations. The research will inform evidence-based policies to sustain access to better care beyond the pandemic and address the ongoing opioid crisis.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
This article discusses the resilience of Indigenous communities in the Arctic during the COVID-19 pandemic. Despite facing vulnerabilities such as limited access to healthcare and infrastructure, these communities had lower COVID-19 death rates compared to southern regions. The article highlights the importance of Indigenous health-care sovereignty and self-determination in controlling the spread of the virus. Indigenous-led decision-making, community-centered approaches, and cultural relevance played a crucial role in mitigating the impact of the pandemic. Recognizing and promoting Indigenous Peoples’ self-determination in healthcare is essential for developing sustainable health-care systems and addressing future health crises.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
This study describes harm reduction and health services provided by the U.S. syringe services programs (SSPs) in 2019 and changes in provision of those services in 2020. Many SSPs that offered health services in 2019 and remained operational in 2020 increased telehealth provision of mental health and primary care services, increased MOUD provision, and expanded harm reduction services, but most SSPs reduced or stopped on-site HIV and HCV testing. With the record high opioid overdose fatality rates in 2020, sustaining the trajectory of SSP growth and innovation leading up to and through 2020 requires ensuring adequate and flexible funding to support the life-saving work of SSPs in preventing future overdose deaths and outbreaks of HIV and HCV.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This article discusses the preliminary data regarding Syringe Services Program (SSP) operational and service delivery changes during the response to the COVID-19 pandemic and provides key policy and service provision implications for SSPs. There is an emphasis on the distribution of services provided at SSPs and highlights the need for SSP support in providing education, prevention, and strategies to avoid emerging infectious disease outbreaks.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
This study recommends that governments should continue to fund and prioritize use of Federally Qualified Health Centers (FQHCs) as major vaccine administration sites. This retrospective cohort study examines COVID-19 vaccination administration rates at FQHCs by race and ethnicity and also the racial and ethnic equity in vaccine receipt at FQHCs. The results of the study found that vaccine administration at FQHCs was equitable for American Indian or Alaska Native, Asian, and Hispanic populations, but there were inequities for the Black population. FQHCs have provided critical access to COVID-19 vaccinations for patients from diverse racial and ethnic groups. This resource may help motivate governments to continue funding and prioritizing the use of FQHCs by showing that these health centers have provided access to COVID-19 vaccinations for patients from diverse economic, racial, and ethnic groups.